Results 31 to 40 of about 29,547 (250)
Pathology of intrahepatic cholangiocarcinoma [PDF]
HepatoBiliary Surgery and Nutrition, 2017 Intrahepatic cholangiocarcinoma (iCC) is a primary carcinoma of the liver with increasing significance and major pathogenic, clinical and therapeutic challenges. Classically, it arises from malignant transformation of cholangiocytes bordering small portal bile duct (BD) to second-order segmental large BDs. It has three major macroscopic growth pattern [
Vijgen, Sandrine Elisabeth V +2 more
openaire +4 more sources
Nationwide treatment and outcomes of intrahepatic cholangiocarcinoma [PDF]
, 2023 Background: Most data on the treatment and outcomes of intrahepatic cholangiocarcinoma (iCCA) derives from expert centers. This study aimed to investigate the treatment and outcomes of all patients diagnosed with iCCA in a nationwide cohort.
Dutch Hepatocellular & Cholangiocarcinoma Group (DHCG)
core
Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma
BMC Cancer, 2022 Background Annexin A10 expression influences the prognosis of several gastrointestinal cancers. We explored the association of annexin A10 expression with the overall survival (OS) of patients who underwent curative surgery for cholangiocarcinoma ...
Yu-Yun Shao +9 more
doaj +1 more source
, 2018 Background: Intrahepatic cholangiocarcinoma with hepatic hilus involvement has been either classified as intrahepatic cholangiocarcinoma or hilar cholangiocarcinoma.
Chen QY +19 more
core +2 more sources
Atypical presentation of intrahepatic cholangiocarcinoma---Fever and ascites in a postpartum lady
Journal of Family Medicine and Primary Care, 2019 Intrahepatic cholangiocarcinoma is an uncommon malignancy which usually occurs in the 7th decade. Here we present a postpartum patient with fever, hepatomegaly, and ascites, who was diagnosed to have metastatic intrahepatic cholangiocarcinoma.
Sohini Das +3 more
doaj +1 more source
Application of Immune Checkpoint Inhibitors in the Treatment of Cholangiocarcinoma
Technology in Cancer Research & Treatment, 2021 Cholangiocarcinoma is a general term for intrahepatic and extrahepatic malignant tumors deriving in the biliary system. According to the location, it is divided into intrahepatic cholangiocarcinoma, hilar cholangiocarcinoma, and distal cholangiocarcinoma.
Fan-li Zeng MD, Jing-fang Chen BD
doaj +1 more source
Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma [PDF]
Clinical and Molecular Hepatology, 2016 A bile duct lesion originating from intrahepatic bile ducts is generally regarded as an incidental pathologic finding in liver specimens. However, a recent study on the molecular classification of intrahepatic cholangiocarcinoma has focused on the ...
Kyoung-Bun Lee
doaj +1 more source
대한영상의학회지, 2017 This report describes a rare case of intrahepatic cholangiocarcinoma, initially presented as a distant metastatic lymph node without demonstrable hepatic mass, in a 37-year-old man. Initially, a solitary cystic mass around the common hepatic artery was
Lyo Min Kwon +4 more
doaj +1 more source
Frontiers in Pharmacology, 2022 Background: Lenvatinib combined with a PD-1 inhibitor has obtained a satisfactory antitumor effect in several solid tumors. However, the efficacy and tumor response of lenvatinib with a PD-1 inhibitor in advanced intrahepatic cholangiocarcinoma still ...
Lulu Xie +10 more
doaj +1 more source
Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI [PDF]
, 2015 PURPOSEWe aimed to gain further insight in magnetic resonance imaging characteristics of mass-forming intrahepatic cholangiocarcinoma (mICC), its enhancement pattern with gadoxetic acid contrast agent, and distinction from poorly differentiated ...
Kousei Ishigami +10 more
core +1 more source